In Africa, pregnant women and young children are the most vulnerable to malaria.

However, malaria control interventions and strategies have achivied important results in the last years.

COVID-19 has now made these interventions critical, and could undo the results obtained so far, as highlighted by scientists in the Lancet: https://bit.ly/2Tfyxwn.

Potentially, COVID-19 could indirectly cause more deaths than it already does directly, in the context of Africa’s weak and fragile health systems.

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

The Congolese National Medicines Regulatory Authority (DPM) with WHO to guarantee the development and circulation of safe and effective drugs, by implementing the Global Benchmarking Tool (GBT)

As part of the strengthening of health systems and in particular the regulation of drugs and health products within the Africlinique project, the headquarters of the World Health Organization (WHO),

Ebola vaccines at a la glance

Ebola vaccine candidates are currently being evaluated in phase I–III clinical trials conducted in Africa, the EU and the US. Although preclinical development of candidate vaccines utilise different platforms, including

SEARCH

SEARCH (SouthErn Africa Regulatory for Clinical researcH) is a consortium of Southern African countries (Mozambique, Swaziland, Lesotho and Botswana) and European Union, aimed to increase the capacity of the National